F. J. C. Roe: I realise that the limb deformities commonly associated with thalidomide exposure in utero are not normally fatal during the first year of life. Nevertheless, I wondered if you could say whether any part of the reduction in infant deaths from congenital abnormalities in recent years might reasonably be attributed to the withdrawal of thalidomide? Also, is there any evidence that the incidence of hydrocephalus has fallen because of a lowered prevalence of toxoplasmosis? It used to be thought that women who handled rabbit meat were at special risk of giving birth to babies affected congenitally with the organism. This may be less of a hazard today. Finally, has prophylactic abortion in cases of rubella infection in early pregnancy had any impact on the figures given in Table 2 of your paper?
P. H. S. Silver: I doubt whether the number of cases of congenital abnormalities attributable to exposure to teratogenic drugs is sufficient for any change in drug usage to be reflected as an overall change in the incidence of abnormalities. It is possible that some effect may be seen in local areas as seems to have been the case in Hamburg at the time of the discovery of the activity of thalidomide. Even in this instance, however, the effect of thalidomide was noticed primarily because of the particular type of abnormality it induced rather than because it increased the incidence of congenital abnormality generally.
I am afraid I do not know the answer to your question with regard to toxoplasmosis. ]n the case of rubella infection, again, the incidence of rubella-induced congenital abnormalities is so low that 1 doubt whether a measure such as prophylactic abortion would make much impression on the overall incidence figures. Perhaps it is worth adding here that the infrequency of rubella in women at the vulnerable stage of pregnancy is one of the reasons why the health authorities do not consider it worth making German measles a generally notifiable disease. (King, 1966) . The form of abnormality which he described in relation to antihistamine administration involves tongue fusion. The phenomenon, therefore, seems to be quite different from the type of cleft palate that we have been studying and not so clinically relevant.
P. H. S.
Silver: Do you believe that experiments on laboratory animals such as those you have described can be of practical help to the clinician in relation to the treatment of congenital abnormalities?
D. E. Poswillo: Tn some cases, yes. Some forms of cleft palate are really defects of moulding so that the tissues, although in the wrong place, are capable of normal growth. In these cases, there may be an optimal time for operation. Tn cases where the defect is associated with a failure in normal growth there may be no point in deferring surgery. One of the purposes of our experiments has been to distinguish between these two classes of abnormality. F. J. C. Roe: I should like to congratulate Mr Palmer on his most impressive survey of the congenital abnormalities which may arise spontaneously in rabbits. However, I should like to question not so much the validity but the value of the theory that teratogens do no more than increase the incidence of phenomena that occur naturally. I would take the view that the ability to develop normally necessarily entails the capacity for developing abnormally. I cannot see, therefore, that the hypothesis states anything more than the obvious. The same argument has, of course, been advanced in relation to carcinogenic activity. That is to say, it has been suggested that carcinogens do no more than increase the incidence of spontaneous neoplasms. In this case, it is somewhat difficult to refute the argument because in carcinogenesis experiments there is no logical endpoint: animals that die from causes other than neoplasia may theoretically have developed neoplasms if they had lived longer. In the case of teratogenicity experiments, however, there is a clear endpoint to the observation period, namely birth. Therefore, it is possible to analyse the results mathematically and to calculate the statistical significance of the results. In this way it is reasonable to deduce the cause and effect relationship between exposure to agent and a raised incidence of congenital abnormalities. This is sufficient information for defining an agent as a teratogen at least for the circumstances in which it was tested. It can only confuse the problem to suggest that in some or all cases agents that give positive results in such tests are really only acting as co-factors and that the important mechanism involved is something that takes place naturally.
A. K. Palmer: I do not disagree with Dr Roe but] should explain that I was looking at the subject from a different viewpoint. My principal concern was that it should be more widely appreciated that virtually all the types of congenital abnormality seen in response to teratogens also occur in the absence of treatment. There is, therefore, a danger that the isolated occurrence of a particular abnormality in a single test may be wrongly attributed to treatment.
I completely endorse Dr Roe's statement that results should be analysed mathematically; unfortunately there is no adequate statistical test to deal with the very low rates of serious malformation encountered in the vast majority of drug evaluation studies. Since malformation rates often follow a binomial distribution, group sizes of 300 or more litters would be necessary to determine statistical significance in many cases.
For evaluation, one must therefore learn to make full use of other parameters correlated with teratogenicity (Palmer, in press ).
F. M. Sullivan: I would suggest that ideally one should use for teratogenicity studies a species of test animal that has a similar rate of congenital abnormality to man, namely 2 to 3 per cent.
A. K. Palmer:
Because it is practically impossible to attain maximum teratogenic expression in screening studies, I recommend the use of a species with a high natural rate of a variety of congenital malformations. For the reasons stated in my paper, such a species is likely also to be susceptible to the induction of abnormalities by exogenous agents. This if I may say so, is the most important corollary of the hypothesis that I put forward. However, extrapolation from animal studies to man is complex and the concept of a 'species of choice' is a myth. Results obtained in a susceptible species should be viewed against the background of information obtained from studies in. other less susceptible species. The results of teratogenicity studies should be considered together with effects on fertility, pregnancy, litter size, foetal weight, etc. and with all available information on the metabolism, pharmacology, and toxicology of the test drug. 
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F. Beck: I suggest that it would be more economical to examine the progeny for congenital abnormalities, not just one day, but one week before parturition.
All the defects visible at birth would be present at this time and the examination would be easier in that the animals would be smaller. The number of abnormalities observed may be greater because of fewer resorptions.
V. Udall: I think it should be made clear that what Miss Cook and Dr
Fairweather have described is a screening test for teratogenic effects. The type of experiment that Dr Beck is proposing is more appropriate to the examination in depth of an apparent teratogenic effect picked up by a screening test.
T. Gillman: I should have thought that the time spent in examining foetuses by the methods you described would have been better spent in the dissection of foetuses on an anatomical basis. You must surely miss abnormalities if all you do is to examine transverse sections of the whole organism. In any case, I should have thought the latter procedure was more time-consuming than dissection.
M. J. Cook:
The method I have described is, in fact, extremely quick and very efficient in picking up abnormalities.
F. A. Fairweather:
It should perhaps be made clear that we are able to examine histological sections prepared from slices if and when such examination is indicated.
F. Beck:
We have used both conventional dissection and the Wilson (1965) technique for the assessment of teratogenic effects, and I am able to confirm that the latter method is at least as efficient as the former in picking up defects.
GENERAL DISCUSSION

W. M. Hollyhock:
It is important to understand that there is a no-man's land between normality and abnormality. At more or less the same time, data on two compounds were sent in for assessment by a drug-safety committee. One of them increased the incidence of 13-rib foetuses in a strain of rabbit that normally has 12 ribs, the other increased the incidence of 12-rib foetuses in a strain that normally has 13 ribs! Whatever tests we make, however many species we study, none of us can be sure that the thalidomide story will not be repeated. We can only hope that teratogenicity screening tests are reducing the likelihood of a fresh disaster, and that increased awareness by clinicians will limit the number of cases attributable to a teratogenic drug that has slipped through the teratogenicity screens.
V. Udall: It is important that teratogenicity tests should not be considered out of the context of full pharmacological and toxicological evaluation. In general, the need in the future is for greater emphasis on metabolic studies. In the design of teratogenicity tests, as in that of tests for other types of toxicity, a knowledge that the metabolic pathways in the test species are similar to those in man is highly desirable, perhaps essential.
F. J. C. Roe: I am always surprised at the readiness with which it is accepted that, whereas groups of say 50 rats are necessary for a meaningful study of a particular aspect of toxicity, if the test species is the dog, data from, say, only 10 animals are sufficient. The fact is that whatever the number of animals used it is both a guess in relation to adequacy and a compromise. It is only ever possible to know how many animals should have been used when the results of the experiment are to hand. If only small numbers of animals are used, the difficulties of statistical evaluation are just as great in the case of dogs as in the case of rats. Emphasis is constantly being put on the desirability of using species other than small rodents. I would suggest that any screening programme should include tests on at least one species in which sufficient numbers of animals can be studied for the purposes of statistical evaluation. Another point that has not been mentioned is that, in some senses, the number of observations in a teratogenicity test is not the number of foetuses examined but the number of mothers injected. Some mothers may, for genetic or environmental reasons, be more prone to give rise to embryos especially susceptible to the induction of abnormalities.
M. W. Parkes:
A fundamental question which has so far been skated around is, what is the predictive value of the tests we have been discussing? F. M. Sullivan: Since so few agents have been shown to be teratogenic in man, it is at present difficult or impossible to answer Dr Parkes' question. Perhaps the most worrying aspect of prediction is the fact that many agents have been found to be teratogenic in animals but not in man. We might, therefore, be being deprived of clinically useful drugs unnecessarily.
W. M. Hollyhock:
In practice one must balance risk and benefit and this is what committees concerned with the safety evaluation of drugs try to do. They do not ban a drug on the basis of a suspected toxic effect, if there are strong indications for its use.
D. C. Roberts:
Perhaps there should be more control of prescribing to pregnant women and to women who might be pregnant.
A. K. Palmer:
One reason for discrepancies between teratogenic effects observed in animals and man may be that in the case of some agents there is only a small margin between the minimal teratogenic dose and the lethal dose. For the same agent, the margin may vary between species and in some there may be no margin. In any case it is not usual for man to be exposed to drugs at doses close to the lethal range. There are, therefore, good reasons for the differences between experimental animals and man referred to by Mr Sul1ivan.
